Jacob Gottlieb, Stuart Weisbrod to Share an Office: Visium, Iguana

Jacob Gottlieb is a hedge fund manager who founded Altium Capital, a healthcare-focused investment firm, after his earlier fund, Visium Asset Management, wound down operations. Gottlieb has built his career around biotech and pharmaceutical investing, backing early-stage healthcare companies — including Oramed Pharmaceuticals, known for developing orally administered insulin, a longstanding goal in diabetes treatment aimed at replacing injectable insulin for some patients.

Stuart Weisbrod, another healthcare-focused investor with a background at Iguana Healthcare Partners, has been associated with similar biotech and life-sciences investment circles.

Coverage of shared office arrangements between healthcare-focused fund managers in New York reflects a broader pattern in the industry: specialist investors in adjacent niches — like biotech and pharma — often cluster together to share research networks, expert-network access, and deal flow.